FDA Warns of Possible Interstitial Lung Disease, Pneumonitis With Certain Breast Cancer Drugs
Healthcare professionals are being advised to monitor patients regularly for pulmonary symptoms indicative of ILD and/or pneumonitis, including hypoxia, cough, dyspnea, and interstitial infiltrates on radiologic exams.